ISRG Beat by Nearly 12%. The Stock Is Down About 42% From Its High.
Robotic surgery posted its best quarter in years. The market responded by selling it.
Robotic surgery posted its best quarter in years. The market responded by selling it.
The FDA ruling changed what PM can legally say about ZYN. Q2 earnings this morning will show if the market…
The CFO already told you Q2 billing growth is running above a three-year high.
The market is pricing in failure. The data is telling a different story.
An 86% EPS beat today just made insurance the most interesting trade in the market.
A $10B Crinetics deal, a fifth commercial pillar, and Q2 earnings that will define the acquisition thesis.
America's aging population isn't just a healthcare story. It's a home infrastructure story.
Inside the invisible material shortage throttling the world's most advanced chip factories.
The stock fell harder than any S&P 500 name on Monday. Here is what actually happened.
CEG completed a $26.6 billion Calpine acquisition and signed long-term nuclear deals with hyperscalers. The valuation is the most interesting…